Galderma Global Research Reveals Struggles of People With Rosacea and Psoriasis of the Face Experiencing a Lack of Contr

A global market research study involving 300 rosacea patients, 318 patients with psoriasis on the face and 361 doctors in 6 different countries (Canada, France, Germany, Italy, Poland and the USA) investigating their experience of living with, or treating patients living with, rosacea or psoriasis of the face. An expert-authored report of the findings was released in May 2020 and seeks to address three key questions - What is the true extent of the burden patients face? How does it differ across the two facial skin diseases? By looking at the impact of facial skin disease from different angles, what insights can we gain to help patients and doctors achieve the best outcomes?

About Galderma

Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galderma.com [http://www.galderma.com/]

Click here to view the survey results infographic: https://mma.prnewswire.com/media/1167325... [https://mma.prnewswire.com/media/1167325...]

Galderma media relations contact: Sébastien Cros
Head of Corporate Communications media@galderma.com[mailto:media@galderma.com]
+41-21-642-76-94

Web site: https://www.galderma.com/